Evidence map›Paper›PMID 40928656›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Evaluation of clozapine forgiveness under imperfect adherence scenarios: a population pharmacokinetic simulation study.

Archana Mishra, Biswa Ranjan Mishra, Debadatta Mohapatra, Anand Srinivasan, Rituparna Maiti, Debasish Hota

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Archana MishraDepartment of Pharmacology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India.ORCID http://orcid.org/0000-0001-8837-299X
Biswa Ranjan MishraDepartment of Psychiatry, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India.ORCID http://orcid.org/0000-0003-0537-9454
Debadatta MohapatraDepartment of Psychiatry, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India.ORCID http://orcid.org/0000-0001-7162-744X
Anand SrinivasanDepartment of Pharmacology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India.ORCID http://orcid.org/0000-0002-0663-0922
Rituparna MaitiDepartment of Pharmacology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India. pharm_rituparna@aiimsbhubaneswar.edu.in.ORCID http://orcid.org/0000-0003-4063-9178
Debasish HotaDepartment of Pharmacology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India.ORCID http://orcid.org/0000-0002-7339-1773

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clozapine, the only drug approved by the FDA for treatment-resistant schizophrenia, operates within a narrow therapeutic range (0.35-0.60 mg/mL) and requires titration from 12.5 to 300-450 mg daily in two divided doses. Non-adherence, driven by adverse effects and logistic barriers, often manifests as missed or delayed doses. Clozapine's forgiveness, i.e., its capacity to sustain efficacy despite dosing errors, is poorly quantified. This study simulated the pharmacokinetics (PK) of clozapine to assess forgiveness across dosing scenarios. A one-compartment PK model (CL = 8.3 L/h, V

Indexed as

Antipsychotic AgentsClozapineForgivenessMedication AdherenceModels, BiologicalSchizophrenia, Treatment-ResistantAdultComputer SimulationDose-Response Relationship, DrugFemaleHumansMaleMiddle AgedYoung AdultAntipsychotic AgentsClozapineClozapineForgivenessImperfect adherenceSimulation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.